{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:10:56Z","timestamp":1769760656662,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.arcmed.2024.102987","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T19:58:35Z","timestamp":1711051115000},"page":"102987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Screening the General Population for Non-Alcoholic Fatty Liver Disease: Model Development and Validation"],"prefix":"10.1016","volume":"55","author":[{"given":"Tanya","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8177-0725","authenticated-orcid":false,"given":"Babak","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2024.102987_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.803967","article-title":"Gender-Based Association of Coronary Artery Calcification and Framingham Risk Score With Non-alcoholic Fatty Liver Disease and Abdominal Obesity in Taiwanese Adults, a Cross-Sectional Study","volume":"9","author":"Tsou","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.arcmed.2024.102987_bib0002","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1016\/j.cgh.2018.12.016","article-title":"Health-related Quality of Life in Nonalcoholic Fatty Liver Disease Associates With Hepatic Inflammation","volume":"17","author":"Huber","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2024.102987_bib0003","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.102987_bib0004","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.arcmed.2024.102987_bib0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3389\/fmed.2019.00202","article-title":"Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review","volume":"6","author":"Ismaiel","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.arcmed.2024.102987_bib0006","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2024.102987_bib0007","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.2337\/dci21-0020","article-title":"Preparing for the NASH Epidemic: A Call to Action","volume":"44","author":"Kanwal","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2024.102987_bib0008","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2021.07.049","article-title":"Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease","volume":"161","author":"Kanwal","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arcmed.2024.102987_bib0009","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000504545","article-title":"Association between Sleep Duration and Incident Chronic Kidney Disease: A Population-Based Cohort Analysis of the NAGALA Study","volume":"45","author":"Nakajima","year":"2020","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.arcmed.2024.102987_bib0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12876-021-01893-4","article-title":"Obesity and metabolic abnormalities as risks of alcoholic fatty liver in men: NAGALA study","volume":"21","author":"Yoshimura","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.arcmed.2024.102987_bib0011","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12876-021-01809-2","article-title":"Clinical characteristics and longitudinal changes of patients with non-alcoholic fatty liver disease in 2 decades: the NAGALA study","volume":"21","author":"Okamura","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.arcmed.2024.102987_bib0012","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41366-018-0076-3","article-title":"Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study","volume":"43","author":"Okamura","year":"2019","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.arcmed.2024.102987_bib0013","unstructured":"[Dataset] Okamura Tea, Data from: Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study, Dryad, Dataset, https:\/\/doi.org\/10.5061\/dryad.8q0p192 (Accessed March 2, 2023)."},{"key":"10.1016\/j.arcmed.2024.102987_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225792","article-title":"ABO blood group and risk of newly diagnosed nonalcoholic fatty liver disease: A case-control study in Han Chinese population","volume":"14","author":"Zhong","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2024.102987_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249223","article-title":"Assessment of the association between body composition and risk of non-alcoholic fatty liver","volume":"16","author":"Ariya","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2024.102987_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266505","article-title":"Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals","volume":"17","author":"Aneni","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.arcmed.2024.102987_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2019-000359","article-title":"Changes in metabolic complications in patients with alcoholic fatty liver disease monitored over two decades: NAGALA study","volume":"7","author":"Hamaguchi","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.arcmed.2024.102987_bib0018","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3748\/wjg.v18.i13.1508","article-title":"Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome","volume":"18","author":"Hamaguchi","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arcmed.2024.102987_bib0019","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","article-title":"The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation","volume":"102","author":"Hamaguchi","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2024.102987_bib0020","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/obr.12407","article-title":"Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies","volume":"17","author":"Li","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/j.arcmed.2024.102987_bib0021","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12944-022-01717-8","article-title":"The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease","volume":"21","author":"Kuang","year":"2022","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.arcmed.2024.102987_bib0022","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.cgh.2021.07.016","article-title":"Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study","volume":"20","author":"Ahmed","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2024.102987_bib0023","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12944-023-01802-6","article-title":"Lipid accumulation product (LAP) index for the diagnosis of nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis","volume":"22","author":"Ebrahimi","year":"2023","journal-title":"Lipids in Health and Disease"},{"key":"10.1016\/j.arcmed.2024.102987_bib0024","first-page":"99","article-title":"Comparison of non-invasive scoring systems with ultrasound and liver elastography in predicting non-alcoholic fatty liver disease in healthy population","volume":"22","author":"Balankhe","year":"2021","journal-title":"J, Ind Acad Clin Med"},{"key":"10.1016\/j.arcmed.2024.102987_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.34172\/mejdd.2020.168","article-title":"Which Metabolic Index is Appropriate for Predicting Non-alcoholic Steatohepatitis?","volume":"12","author":"Jamali","year":"2020","journal-title":"Middle East J Dig Dis"},{"key":"10.1016\/j.arcmed.2024.102987_bib0026","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","article-title":"Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal","volume":"58","author":"Machado","year":"2013","journal-title":"J Hepatol"},{"issue":"Suppl","key":"10.1016\/j.arcmed.2024.102987_bib0027","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.3350\/cmh.2022.0336","article-title":"Screening strategy for non-alcoholic fatty liver disease","volume":"29","author":"Zhang","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.arcmed.2024.102987_bib0028","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2024.102987_bib0029","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.arcmed.2024.102987_bib0030","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.3748\/wjg.v22.i10.3023","article-title":"Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease","volume":"22","author":"Motamed","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.arcmed.2024.102987_bib0031","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.arcmed.2024.102987_bib0032","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29797","article-title":"Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials","volume":"68","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.arcmed.2024.102987_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092251","article-title":"Triglyceride Glucose-Waist Circumference (TyG-WC) Is a Reliable Marker to Predict Non-Alcoholic Fatty Liver Disease","volume":"10","author":"Song","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.arcmed.2024.102987_bib0034","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.jhep.2020.06.025","article-title":"Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials","volume":"73","author":"Davison","year":"2020","journal-title":"J Hepatol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440924000407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440924000407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T13:42:05Z","timestamp":1713447725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440924000407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0188440924000407"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2024.102987","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening the General Population for Non-Alcoholic Fatty Liver Disease: Model Development and Validation","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2024.102987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102987"}}